SCM Lifescience Co., Ltd. Stock

Equities

A298060

KR7298060005

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
2,560 KRW -1.35% Intraday chart for SCM Lifescience Co., Ltd. -7.91% -32.28%
Sales 2022 396M 287K Sales 2023 696M 504K Capitalization 77.37B 56.09M
Net income 2022 -22.93B -16.62M Net income 2023 -23.96B -17.37M EV / Sales 2022 434 x
Net cash position 2022 3.2B 2.32M Net cash position 2023 8.52B 6.18M EV / Sales 2023 99 x
P/E ratio 2022
-6.35 x
P/E ratio 2023
-2.58 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 82.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.35%
1 week-7.91%
Current month-17.68%
1 month-14.09%
3 months-16.34%
6 months+13.78%
Current year-32.28%
More quotes
1 week
2 535.00
Extreme 2535
2 680.00
1 month
2 520.00
Extreme 2520
3 250.00
Current year
2 520.00
Extreme 2520
4 300.00
1 year
2 060.00
Extreme 2060
11 583.33
3 years
2 060.00
Extreme 2060
33 875.00
5 years
2 060.00
Extreme 2060
50 250.00
10 years
2 060.00
Extreme 2060
50 250.00
More quotes
Managers TitleAgeSince
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - 14-07-01
Members of the board TitleAgeSince
Director/Board Member 60 -
More insiders
Date Price Change Volume
24-04-19 2,560 -1.35% 38,989
24-04-18 2,595 +1.17% 26,008
24-04-17 2,565 -2.47% 37,727
24-04-16 2,630 -0.75% 58,899
24-04-15 2,650 -4.68% 78,556

End-of-day quote Korea S.E., April 18, 2024

More quotes
SCM Lifescience Co Ltd is a Korea-based company engaged in the research and development of medicines. The Company is engaged in the business of the development and production of cell therapy products, the agency testing of cell production and quality, adult stem cell consulting, cosmetics manufacturing, and hair growth protein manufacturing.
More about the company
  1. Stock Market
  2. Equities
  3. A298060 Stock